ketoconazole has been researched along with piperonyl butoxide in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (16.67) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 3 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Jacobs, JM; Lambrecht, RW; Sinclair, JF; Sinclair, PR | 1 |
McLean, S; Pass, GJ | 1 |
Ballent, M; Lanusse, C; Lifschitz, A; Sallovitz, J; Scarcella, S; Virkel, G | 1 |
Kubickova, B; Martinkova, M; Stiborova, M | 1 |
6 other study(ies) available for ketoconazole and piperonyl butoxide
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Effects of iron-EDTA on uroporphyrinogen oxidation by liver microsomes.
Topics: Animals; Catalase; Chick Embryo; Edetic Acid; Ferric Compounds; Iron Chelating Agents; Ketoconazole; Mice; Microsomes, Liver; Oxidation-Reduction; Piperonyl Butoxide; Polychlorinated Biphenyls; Porphyrinogens; Superoxide Dismutase; Uroporphyrinogens | 1989 |
Inhibition of the microsomal metabolism of 1,8-cineole in the common brushtail possum (Trichosurus vulpecula) by terpenes and other chemicals.
Topics: Animals; Anti-Infective Agents, Local; Aryl Hydrocarbon Hydroxylases; Cyclohexanols; Cytochrome P-450 CYP2E1; Cytochrome P-450 CYP3A; Ditiocarb; Dose-Response Relationship, Drug; Eucalyptol; Humans; Hydroxylation; Ketoconazole; Kinetics; Magnetic Resonance Spectroscopy; Male; Microsomes, Liver; Monoterpenes; Opossums; Oxidoreductases, N-Demethylating; Pesticide Synergists; Piperonyl Butoxide; Rats; Rats, Wistar; Terpenes | 2002 |
Inhibition of cytochrome P450 activity enhances the systemic availability of triclabendazole metabolites in sheep.
Topics: Animals; Animals, Newborn; Anthelmintics; Area Under Curve; Benzimidazoles; Biological Availability; Chromatography, High Pressure Liquid; Cytochrome P-450 Enzyme Inhibitors; Female; Ketoconazole; Methimazole; Piperonyl Butoxide; Random Allocation; Sheep; Triclabendazole | 2009 |
Effects of cytochrome P450 inhibitors on peroxidase activity.
Topics: Benzoflavones; Cytochrome P-450 Enzyme Inhibitors; Disulfiram; Ditiocarb; Ellipticines; Enzyme Activation; Enzyme Inhibitors; Horseradish Peroxidase; Humans; Ketoconazole; Metyrapone; Piperonyl Butoxide; Proadifen; Quinidine; Structure-Activity Relationship; Substrate Specificity; Sulfaphenazole; Triazoles; Troleandomycin | 2012 |